Your browser doesn't support javascript.
loading
Carboplatin/paclitaxel versus cisplatin/paclitaxel as first-line chemotherapy in advanced ovarian cancer: an interim analysis of a randomized phase III trial of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group.
du Bois, A; Lück, H J; Meier, W; Möbus, V; Costa, S; Richter, B; Warm, M; Bauknecht, T; Schröder, W; Olbricht, S; Nitz, U; Jackisch, C.
Affiliation
  • du Bois A; St Vincentius Krankenhäuser, Karlsruhe, Germany.
Semin Oncol ; 24(5 Suppl 15): S15-44-S15-52, 1997 Oct.
Article in En | MEDLINE | ID: mdl-9346222
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Carboplatin / Paclitaxel / Antineoplastic Agents / Antineoplastic Agents, Phytogenic Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Middle aged Country/Region as subject: Europa Language: En Journal: Semin Oncol Year: 1997 Type: Article Affiliation country: Germany
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Carboplatin / Paclitaxel / Antineoplastic Agents / Antineoplastic Agents, Phytogenic Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Middle aged Country/Region as subject: Europa Language: En Journal: Semin Oncol Year: 1997 Type: Article Affiliation country: Germany